NCT02795858 A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors Status COMPLETED Phase PHASE2
NCT02787369 ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02783625 Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas Status COMPLETED Phase PHASE1
NCT02770014 Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer Status TERMINATED Phase PHASE2
NCT02766465 Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) Status COMPLETED Phase PHASE2
NCT02764541 Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02756390 CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors Status COMPLETED Phase NA
NCT02752061 Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care Status COMPLETED Phase NA
NCT02730039 Meaning-Centered Psychotherapy Training for Cancer Care Providers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02724904 Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT02724878 Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02706249 Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients Status COMPLETED Phase PHASE2
NCT02698891 Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer Status COMPLETED Phase PHASE2
NCT02689401 MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer Status WITHDRAWN Phase PHASE1